News + Font Resize -

Generex expands commercialisation plans, appoints Stephen Fellows as VP, finance
Worcester, MA | Wednesday, June 24, 2009, 08:00 Hrs  [IST]

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced the appointment of Stephen Fellows, CA to the position of vice president of finance as the company plans for growth in sales for its current retail product portfolio and increased commercialization for its flagship oral insulin product Generex Oral-lyn.

Fellows has approximately 20 years of experience in financial management and accounting reporting for both public and private companies. As vice president of finance he will be instrumental in helping to direct and oversee company financial and accounting procedures while providing strategic planning for creating future revenue streams including joint ventures and licensing arrangements for the company's current portfolio of products as well as its robust product development pipeline.

"Stephen's extensive experience is an added value to the company and a superb choice for vice president of finance," said Rose C Perri, the company's chief financial and operating officer. "His appointment comes at a time where we anticipate the beginning of our transition from research and development to product commercialization in a number of key areas including the continued expansion of our sales efforts for our flagship product Generex Oral-lyn which entails sophisticated financial planning within international markets."

Prior to joining Generex, Fellows spent almost four years at Sona Mobile Holdings Corporation, a publicly held software company which developed software applications for mobile devices, where he served as chief financial officer. Fellows joined Sona Mobile from 3Com Corporation, where he was the director of finance of the corporate accounting group in Marlborough. Prior to that, Fellows spent five years as the director of finance & operations of 3Com's Canadian subsidiary. Fellows joined 3Com from Pennzoil Corporation where he spent time in the international mergers and acquisitions group in Houston, Texas, as well as four years as controller for Pennzoil Canada.

Fellows holds a Bachelor of Business Administration degree from Wilfrid Laurier University in Waterloo, Ontario, Canada and earned his chartered accountants designation while articling with Arthur Andersen & Company in Toronto.

Generex is engaged in the research, development and commercialization of drug delivery systems and technologies.

Post Your Comment

 

Enquiry Form